Phathom Pharma To Make Stock Market Debut On Oct.25

Phathom Pharmaceuticals Inc., a late clinical-stage biopharmaceutical company developing treatments for gastrointestinal diseases, is all set to list its common stock on the Nasdaq Global Market under the symbol "PHAT" on October 25, 2019.

from RTT - Biotech https://ift.tt/2pMg92w
via IFTTT